Black Maple Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Black Maple Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,000	Closed	-$664K	–	102
2024 Q2	$664K	Hold	16,000	–	–	0.43%	45
2024 Q1	$868K	Buy	16,000 +1,000	+7%	+$50.9K	0.53%	43
2023 Q4	$770K	Hold	15,000	–	–	0.64%	33
2023 Q3	$871K	Buy	15,000 +10,000	+200%	+$613K	0.59%	29
2023 Q2	$320K	Buy	+5,000	New	+$335K	0.19%	60

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Black Maple Capital Management's BMY Position: Q3 2024 in Review

Black Maple Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 16,000 shares — an estimated $664K sold.

Black Maple Capital Management first reported a position in BMY in Q2 2023 and held it in 5 quarters. The position peaked at $871K in Q3 2023. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Black Maple Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Black Maple Capital Management sold 16,000 Bristol-Myers Squibb shares in Q3 2024, an estimated $664K.
Black Maple Capital Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 5 quarters.
Black Maple Capital Management's Bristol-Myers Squibb position peaked at $871K in Q3 2023.
2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Black Maple Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.